Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2025-12-17 @ 4:31 AM
Study NCT ID:
NCT04506554
Status:
None
Last Update Posted:
2025-07-04 00:00:00
First Post:
2020-07-30 00:00:00
Brief Title:
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer
Sponsor:
Fox Chase Cancer Center
Organization:
Fox Chase Cancer Center
Organization Data
Organization:
Fox Chase Cancer Center
Class:
OTHER
Study ID:
GU-176
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fox Chase Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None